BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 11226217)

  • 1. Active site mutant transgene confers tolerance to human beta-glucuronidase without affecting the phenotype of MPS VII mice.
    Sly WS; Vogler C; Grubb JH; Zhou M; Jiang J; Zhou XY; Tomatsu S; Bi Y; Snella EM
    Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2205-10. PubMed ID: 11226217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of MPS VII mouse (Gus(tm(hE540A x mE536A)Sly)) doubly tolerant to human and mouse beta-glucuronidase.
    Tomatsu S; Orii KO; Vogler C; Grubb JH; Snella EM; Gutierrez M; Dieter T; Holden CC; Sukegawa K; Orii T; Kondo N; Sly WS
    Hum Mol Genet; 2003 May; 12(9):961-73. PubMed ID: 12700165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Missense models [Gustm(E536A)Sly, Gustm(E536Q)Sly, and Gustm(L175F)Sly] of murine mucopolysaccharidosis type VII produced by targeted mutagenesis.
    Tomatsu S; Orii KO; Vogler C; Grubb JH; Snella EM; Gutierrez MA; Dieter T; Sukegawa K; Orii T; Kondo N; Sly WS
    Proc Natl Acad Sci U S A; 2002 Nov; 99(23):14982-7. PubMed ID: 12403825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel model of murine mucopolysaccharidosis type VII due to an intracisternal a particle element transposition into the beta-glucuronidase gene: clinical and pathologic findings.
    Vogler C; Levy B; Galvin N; Sands MS; Birkenmeier EH; Sly WS; Barker J
    Pediatr Res; 2001 Mar; 49(3):342-8. PubMed ID: 11228259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lentiviral-mediated gene therapy results in sustained expression of β-glucuronidase for up to 12 months in the gus(mps/mps) and up to 18 months in the gus(tm(L175F)Sly) mouse models of mucopolysaccharidosis type VII.
    Derrick-Roberts AL; Pyragius CE; Kaidonis XM; Jackson MR; Anson DS; Byers S
    Hum Gene Ther; 2014 Sep; 25(9):798-810. PubMed ID: 25003807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of lysosomal storage disease in MPS VII mice using a recombinant adeno-associated virus.
    Watson GL; Sayles JN; Chen C; Elliger SS; Elliger CA; Raju NR; Kurtzman GJ; Podsakoff GM
    Gene Ther; 1998 Dec; 5(12):1642-9. PubMed ID: 10023443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloning of the canine beta-glucuronidase cDNA, mutation identification in canine MPS VII, and retroviral vector-mediated correction of MPS VII cells.
    Ray J; Bouvet A; DeSanto C; Fyfe JC; Xu D; Wolfe JH; Aguirre GD; Patterson DF; Haskins ME; Henthorn PS
    Genomics; 1998 Mar; 48(2):248-53. PubMed ID: 9521879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Widespread biochemical correction of murine mucopolysaccharidosis type VII pathology by liver hydrodynamic plasmid delivery.
    Richard M; Arfi A; Seguin J; Gandolphe C; Scherman D
    Gene Ther; 2009 Jun; 16(6):746-56. PubMed ID: 19357715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene transfer of low levels of beta-glucuronidase corrects hepatic lysosomal storage in a large animal model of mucopolysaccharidosis VII.
    Wolfe JH; Sands MS; Harel N; Weil MA; Parente MK; Polesky AC; Reilly JJ; Hasson C; Weimelt S; Haskins ME
    Mol Ther; 2000 Dec; 2(6):552-61. PubMed ID: 11124056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo treatment of hemophilia A and mucopolysaccharidosis type VII using nonprimate lentiviral vectors.
    Stein CS; Kang Y; Sauter SL; Townsend K; Staber P; Derksen TA; Martins I; Qian J; Davidson BL; McCray PB
    Mol Ther; 2001 Jun; 3(6):850-6. PubMed ID: 11407898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of MPS IVA mouse (Galnstm(hC79S.mC76S)slu) tolerant to human N-acetylgalactosamine-6-sulfate sulfatase.
    Tomatsu S; Gutierrez M; Nishioka T; Yamada M; Yamada M; Tosaka Y; Grubb JH; Montaño AM; Vieira MB; Trandafirescu GG; Peña OM; Yamaguchi S; Orii KO; Orii T; Noguchi A; Laybauer L
    Hum Mol Genet; 2005 Nov; 14(22):3321-35. PubMed ID: 16219627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single-base-pair deletion in the beta-glucuronidase gene accounts for the phenotype of murine mucopolysaccharidosis type VII.
    Sands MS; Birkenmeier EH
    Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6567-71. PubMed ID: 8101990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational analysis in longest known survivor of mucopolysaccharidosis type VII.
    Storch S; Wittenstein B; Islam R; Ullrich K; Sly WS; Braulke T
    Hum Genet; 2003 Feb; 112(2):190-4. PubMed ID: 12522561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction of lysosomal storage in the liver and spleen of MPS VII mice by implantation of genetically modified skin fibroblasts.
    Moullier P; Bohl D; Heard JM; Danos O
    Nat Genet; 1993 Jun; 4(2):154-9. PubMed ID: 8348154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delivery of a retroviral vector expressing human beta-glucuronidase to the liver and spleen decreases lysosomal storage in mucopolysaccharidosis VII mice.
    Gao C; Sands MS; Haskins ME; Ponder KP
    Mol Ther; 2000 Sep; 2(3):233-44. PubMed ID: 10985954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis of feline beta-glucuronidase deficiency: an animal model of mucopolysaccharidosis VII.
    Fyfe JC; Kurzhals RL; Lassaline ME; Henthorn PS; Alur PR; Wang P; Wolfe JH; Giger U; Haskins ME; Patterson DF; Sun H; Jain S; Yuhki N
    Genomics; 1999 Jun; 58(2):121-8. PubMed ID: 10366443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzyme replacement in murine mucopolysaccharidosis type VII: neuronal and glial response to beta-glucuronidase requires early initiation of enzyme replacement therapy.
    Vogler C; Levy B; Galvin NJ; Thorpe C; Sands MS; Barker JE; Baty J; Birkenmeier EH; Sly WS
    Pediatr Res; 1999 Jun; 45(6):838-44. PubMed ID: 10367775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzyme replacement with recombinant beta-glucuronidase in murine mucopolysaccharidosis type VII: impact of therapy during the first six weeks of life on subsequent lysosomal storage, growth, and survival.
    Vogler C; Sands MS; Levy B; Galvin N; Birkenmeier EH; Sly WS
    Pediatr Res; 1996 Jun; 39(6):1050-4. PubMed ID: 8725268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Murine mucopolysaccharidosis type VII: the impact of therapies on the clinical course and pathology in a murine model of lysosomal storage disease.
    Vogler C; Sands MS; Galvin N; Levy B; Thorpe C; Barker J; Sly WS
    J Inherit Metab Dis; 1998 Aug; 21(5):575-86. PubMed ID: 9728337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of murine mucopolysaccharidosis type VII by syngeneic bone marrow transplantation in neonates.
    Sands MS; Barker JE; Vogler C; Levy B; Gwynn B; Galvin N; Sly WS; Birkenmeier E
    Lab Invest; 1993 Jun; 68(6):676-86. PubMed ID: 8515654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.